Venting during venoarterial extracorporeal membrane oxygenation

Area of Science:

• Cardiovascular Medicine
• Critical Care Medicine
• Medical Technology

Background:

• Cardiogenic shock and cardiac arrest are leading causes of mortality in acute cardiovascular care.
• Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is an established therapy for these conditions, providing temporary circulatory support.
• Despite its use, in-hospital mortality remains high at approximately 60%.

Purpose of the Study:

• To review existing venting strategies for VA-ECMO.
• To analyze the hemodynamic characteristics of different venting modalities.
• To discuss outcome data and complication rates associated with each venting option.

Main Methods:

• Literature review of existing venting strategies for VA-ECMO.
• Analysis of hemodynamic effects, including left ventricular afterload and filling pressures.
• Evaluation of outcome data and complication rates for various venting approaches.

Main Results:

• VA-ECMO can cause detrimental effects like increased left ventricular afterload and pulmonary congestion.
• Various venting strategies exist to mitigate these adverse effects.
• The ARREST trial showed reduced mortality in cardiac arrest patients treated with VA-ECMO compared to standard care.

Conclusions:

• Effective venting is essential to manage VA-ECMO complications and improve patient outcomes.
• Ongoing studies (EURO-SHOCK, ECLS-SHOCK) will further evaluate VA-ECMO's role in cardiogenic shock.
• This review provides a comprehensive overview of VA-ECMO venting strategies and their associated outcomes.